Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-16

FDA Approved: METRONIDAZOLE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for METRONIDAZOLE submitted by Prasco Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METRONIDAZOLE (Metronidazole)

Snippet

SUPPL AP for METRONIDAZOLE (METRONIDAZOLE)